SciSparc Stock Soars Pre-Market After Snapping Up Patents For Next-Gen Endoscopy Tech

In return, SciSparc shall issue to Xylo an amount of ordinary shares of the company.
Rising stock market chart on a trading board background.
Rising stock market chart on a trading board background. | Image source: Yuichiro Chino on Getty Images
Profile Image
Anan Ashraf·Stocktwits
Published Nov 26, 2025   |   8:24 AM EST
Share
·
Add us onAdd us on Google

SciSparc Ltd. (SPRC) on Wednesday said that its unit NeuroThera Labs Inc. signed a binding term sheet to acquire a treasury of patents, trademarks and intellectual property rights for innovative endoscopic systems and medical cameras from Xylo Technologies Ltd.

Shares of the company jumped 28% in the pre-market session at the time of writing.

The company said it is also acquiring intellectual property rights to the MUSE system, a single-use, innovative endoscopic device designed for a minimally invasive procedure to treat gastroesophageal reflux disease. In return, SciSparc shall issue to Xylo an amount of ordinary shares of the company. 

Get updates to this developing story directly on Stocktwits.

Share
·
Add us onAdd us on Google
Read about our editorial guidelines and ethics policy